About us - Aumed, a.s.

ABOUT COMPANY

The company AUMED, a.s. focuses primarily on three research and development activities, specifically on the research and development of immunobiological preparations such as bacterial vaccines and immunomodulators, and then on the issue of bacteriophages. In recent years, the company has registered increased interest, especially from foreign business partners, in alternative medicinal products that would replace the current massive use of antibiotics.

The company currently has three locations (Brno, Roztoky, Benátky n/J.) and an office in Prague.

The workplace in Brno at the address Karásek 1, Brno – Řečkovice is equipped with clean rooms that meet the requirements for cleanliness classes A, B and C. The building structure, technological background, equipment and professional staff allow the workplace to be used even in the GMP regime. The technological equipment is oriented mainly to work with microbial material and to immunobiological issues in general. It is suitable not only for pharmaceutical production implementations, but also for pharmaceutical research and development both in-house and for a wide range of contractual activities.

The workplace in Roztoky is located on the premises of VUAB. This workplace serves as a R&D facilities for AUMED, a.s. The workplace is also equipped with research laboratories, including an analytical laboratory.

The workplace at 5. května 301, 294 71 Benátky nad Jizerou was opened in early 2024. This workplace is equipped with research laboratories, including a microbiological and analytical laboratory. The workplace is also equipped with clean rooms of cleanliness class D, which are used both in-house and for a wide range of contractual activities. There is also a reserve space in the place, which we would like to use in the future for the production of a new medicinal product containing human transfer factor as an effective medicinal substance. The new medicinal product is based on the results of our own research activities and is currently in the clinical trials phase.

SUBSIDIARY COMPANIES

Under the company AUMED, a.s. also include AUMED Immunology a.s. and AUMED Pharma a.s., which were founded with their own business goals. You can learn more about these companies and their goals here:

COMPANY PHILOSOPHY

Our research is primarily aimed at improving the health of the entire population, which is the cornerstone of the society's function.

Excessive use of antibiotics in healthcare has led to the rise of multi-resistant and pan-resistant strains of bacteria. This has created a serious problem in the field of veterinary and human medicine in the fight against infectious diseases. The same problem are residues in foods that have a negative impact on human health, especially negative for the immune system. Today’s interest is mainly in non-antibiotic and non-generic preparations based on bacteriophage probiotics and enzyme therapy.

Research and subsequent implementation in these areas would reduce the waste burden on the environment, have a positive impact on regional growth and create new jobs with the possibility of involving university students.

RESEARCH PROJECTS

ENZYMES

Development of new enzymatic preparations for the treatment of the most common causative agents of acute and chronic bacterial skin and subcutaneous diseases.

LEARN MORE

WHOOPING COUGH

Development of a completely new generation of pertussis vaccine with significantly improved performance properties.

LEARN MORE

TRANSFER FACTOR

Research and development of transfer factors intended for human therapy.

LEARN MORE

ORAL VACCINE ADMINISTRATION

Development of a microbial vaccine in the form of a lyophilized tablet for oral administration.

LEARN MORE

S. AUREUS VACCINE

Development of a new vaccine against Staphylococcus aureus.

LEARN MORE

ATOPIC ECZEMA

Development of a preparation based on a cleansing spray intended for the supportive treatment of the skin in case of atopic eczema.

LEARN MORE

ACNE VULGARIS

Development of a preparation containing bacteriophages that effectively decolonizes acneic skin from S. aureus and C. acnes bacteria.

LEARN MORE

BACTERIAL VAGINOSIS

Development of an antibacterial phage preparation for local application into the vaginal cavity, intended for the treatment of recurrent bacterial vaginosis.

LEARN MORE

DIAGNOSTICS

AUMED a.s. was also involved in the fight against the Covid-19 pandemic. In cooperation with Protean s.r.o. and Institute of Molecular and Translational Medicine, AUMED a.s. launched a modern diagnostics of SARS-CoV-2 virus under the name AUMED test RT-LAMP Assay SARS-CoV-2.

AUMED, a.s. launched also its own self-sampling set based on the principle of gargling of the oral cavity and pharynx.

With this step, the company significantly expanded its portfolio of professional activities!

AUMED test RT-LAMP Assay SARS-CoV-2

AUMED a.s. launched a modern diagnostics of SARS-CoV-2 virus under the name AUMED test RT-LAMP Assay SARS-CoV-2.

LEARN MORE

PCR GARGLING KIT

Self-collection gargle kit for the detection of viral diseases

LEARN MORE

PRODUCTION

The company AUMED carries out contract manufacturing of pharmaceutical and cosmetic products.

PHAGE GLOW

Dermocosmetic preparations specifically targeted at acneic and eczematous skin.

LEARN MORE

STAFAL

A medicine that, based on bacteriophage, as an active substance, addresses one of the possible alternative ways to combat the growing resistance to antibiotics.

LEARN MORE

EXPERT AND ADVISORY ACTIVITIES

AUMED, a.s. focuses its professional activities on highly specific immunobiological issues.

AUMED, a.s. solves research projects in the field of bacterial vaccines (pertussis vaccine – Bordetella pertussis) and immunomodulators (transfer factor innovation).

In addition to its own research and development activities, it uses its expertise for consulting, advisory and training activities for external entities. These are highly specified pharmaceutical professional activities with an emphasis on GMP (Good Manufacturing Practice), which are actively required by external companies.

LEARN MORE

References:

Hematology and Blood Transfusion Institute – training and expert activities of AUMED a.s. personnel concerning the implementation of GMP in the area of ATMP (Advanced Therapy Medicinal Products). Consultations with SÚKL. Company audits participation.

Institutul Pasteur Romania – experts activities concerning the construction project of a new manufacturing areal for pharmaceutical manufacture.

Co Antigen Ltd, Research and Prouction Center the Republic of Kazakhstan, Almaty – expert activities concerning the implementation of GMP in pharmaceutical manufacture. Personnel training. Practical training. Representation before government authority.

EBRD – European Bank for Reconstruction and Development – AUMED a.s. personnel are registered as expert counsel to the bank in the area of pharmaceutical issues for small companies. For this purpose, they are being retained by the Bank of London for specific projects realized by the bank abroad.

ICRC (International Clinical Research Center St. Anne’s Faculty – consultancy activities for the implementation of GMP in the entire process – specifically, project participation, construction realization consultation, technological assembly implementation, validation issues, documents creation, personnel training etc.

Macromolecular Chemistry Institute AV ČR – BIOCEV department – (Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University in Vestec). Consultancy activities for the implementation of GMP in the entire process – specifically, project participation, SÚK project consultation, construction realization consultation, technological assembly implementation, validation issues, documents creation, personnel training etc.